News & Trends - MedTech & Diagnostics
MTAA slams private health insurers over unused member funds
MedTech News: Private health insurers collected a staggering $1.8 billion in profits over the past year by collecting more in premiums from members while paying out less in claims, according to the Medical Technology Association of Australia (MTAA). MTAA has called for these profits to be immediately returned to members through premium reductions to increase the affordability of private healthcare.
“This week’s data is further evidence that the COVID-19 pandemic has delivered a financial windfall for big corporate insurers, in contrast to the hardship experienced by many of their members,” said Ian Burgess, MTAA CEO.
The quarterly report from the Australian Prudential Regulation Authority (APRA) shows that private health insurer profits soared in the year to September 2021. Between September 2020 and September 2021 health funds’ net investment income rose a staggering 332.9% ($131.9m to $571.0m) and net profits are up 212.4% ($587.4m to $1.8bn).
According to APRA, these gains are likely due to a number of factors, including growth in premiums and lower than anticipated claims.
On the plus side, MTAA was pleased to see that Australians benefited from nearly 3.4m devices implanted in the last year by their clinicians. Average benefits for prostheses are now on average nearly 16% lower than they were 5 years ago delivering increased savings to insurers of over $1.4b since 2017.
“This $1.8 billion profit belongs to policy holders and not the shareholders of corporate insurance companies, many of whom live overseas and have no interest in improving healthcare in Australia,” Mr Burgess commented.
“They should be forced to return these substantial profits to their members who continued to pay for their premiums during the pandemic, despite the restrictions on their access to care. MTAA does not believe that people with private health insurance should pay more for their insurance while shareholders pocket increased dividends.
“We know that insurers are unlikely to pass on these savings unless forced to do so. MTAA has been calling on insurers to pass on the estimated $900m in savings delivered by the medical technology sector as part of our 2017 agreement with the government. Unfortunately there is no evidence that this has occurred.
“Given the clear statement from APRA that insurers should not gain financially from COVID-19, we call on the government to explore all legislative and regulatory options to ensure the insurers’ COVID bonus is returned to members and not used to increase management bonuses and shareholder profits,” Mr Burgess said.
APRA also recently released the latest annual data on private health insurers, covering registered private health insurers’ expenses, revenues, and operational information for the financial year 2020-21 (FY2020-21).
It showed that the Private Health Insurance (PHI) industry’s total revenue hit $26.4 billion, total fund benefits $21.9 billion, total expenses $2.5 billion, and surplus (deficit) after tax of $1.5 billion for FY2020-21.
Among all private health insurers, Medibank Private recorded the highest total revenue, with $6.7 billion while BUPA took the second place with $6.6 billion total revenue. They were followed by Hospitals Contribution Fund of Australia with $3.3 billion total revenue, NIB Health Funds with $2.3 billion, and HBF Health with $1.7 billion. CBHS Corporate Health had the lowest total revenue, with $4,241,000.
Human Resources
Medtronic HR Director deep dives into shifting workplaces and leadership trends: International HR Day
People & Culture: Coinciding with International HR Day, Karen Newell, Senior HR Director for ANZ at Medtronic, joined Health Industry […]
MoreNews & Trends - MedTech & Diagnostics
Aussie medtech reveals new data on next-gen pulsed field ablation system for atrial fibrillation
MedTech & Diagnostics News: An Australian-based medtech company announced promising results from the first-in-human study for its pulsed field ablation […]
MoreNews & Trends - MedTech & Diagnostics
Federal budget delivers ‘mixed news’ for radiologists
MedTech & Diagnostics News: The Royal College of Australian and New Zealand Radiologists (RANZCR) and the Interventional Radiology Society of […]
MoreNews & Trends - Pharmaceuticals
AstraZeneca, BMS and Noxopharm address findings of inquiry report into rare cancers
Pharma News: The Senate Community Affairs References Committee has released its inquiry report into Equitable access to diagnosis and treatment […]
More